- By insider

Chairman & CEO of Pfizer Inc (30-Year Financial, Insider Trades) Albert Bourla (insider trades) sold 132,508 shares of PFE on 11/09/2020 at an average price of $41.94 a share. The total sale was $5.6 million.

• Warning! GuruFocus has detected 2 Warning Sign with DJCO. Click here to check it out.

• PFE 15-Year Financial Data

• The intrinsic value of PFE

• Peter Lynch Chart of PFE

Pfizer Inc is a biopharmaceutical company that discovers, develops, manufactures, and markets healthcare products including medicines, and vaccines as well as many of the consumer healthcare products. Pfizer Inc has a market cap of $215 billion; its shares were traded at around $38.68 with a P/E ratio of 24.95 and P/S ratio of 4.46. The dividend yield of Pfizer Inc stocks is 3.92%. Pfizer Inc had annual average EBITDA growth of 3.90% over the past ten years.

CEO Recent Trades:

• Chairman & CEO Albert Bourla sold 132,508 shares of PFE stock on 11/09/2020 at the average price of $41.94. The price of the stock has decreased by 7.77% since.

Directors and Officers Recent Trades:

• Executive Vice President Sally Susman sold 43,662 shares of PFE stock on 11/09/2020 at the average price of $41.94. The price of the stock has decreased by 7.77% since.

For the complete insider trading history of PFE, click here

.This article first appeared on GuruFocus.